Cost-Utility Analysis of Total Ankle Replacement Compared with Ankle Arthrodesis for Patients Aged 50-85 Years with End-Stage Ankle Osteoarthritis: The TARVA Study.
Andrew J GoldbergEkaterina BordeaKashfia ChowdhuryIva HauptmannovaJames BlackstoneDeirdre BrookingElizabeth L DeaneStephen BendallAndrew BingChris BlundellSunil DharAndrew MolloySteve MilnerMike KarskiSteve HeppleMalik SiddiqueDavid T LovedayViren MishraPaul CookePaul HalliwellDavid TownshendSimon S SkeneCaroline J Dorénull nullPublished in: PharmacoEconomics - open (2024)
TAR does not appear to be cost effective over AF 52 weeks post-operation. A decision model suggests that TAR can be cost effective over the patients' lifetime but there is a need for longer-term prospectively collected data. Clinical trial registration ISRCTN60672307 and ClinicalTrials.gov NCT02128555.